Clinical Trial

A Study of Probiotics in Patients With Acute Ischemic Stroke

Study acronym: PRO-STROKE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the effect of daily oral administration of the probiotic supplement OMNi-BiOTiC® SR-9 for 90 days, compared to placebo, on gut microbiome beta diversity in patients aged 60 years or older with acute ischemic stroke.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-11.
Trial Details
NCT Number NCT07651332
Lead Sponsor Capital Medical University
Conditions Ischemic Stroke
Enrollment 220 participants
Start Date 2026-09-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-17